Table 2 Criteria appraised by experts: Round 1 Questionnaire
From: Prioritisation criteria for the selection of new diagnostic technologies for evaluation
Percent ranking 6 or 7 | |
|---|---|
Regarding the disease or target condition | |
1. The disease or target condition to which the diagnostic technology will be applied can be clearly defined. | 73% |
2. The prevalence or incidence of the disease or target condition. | 58% |
3. The potential that the technology will have an impact on morbidity and/or mortality of the disease or target condition. | 88% |
4. The relevance of the disease or target condition to current regional or national health policies and/or priorities. | 23% |
5. The accuracy of the current diagnostic approach for the disease or target condition is problematic. | 65% |
6. There is variation in treatment or patient outcomes resulting from current diagnostic variability. | 58% |
7. The current diagnostic pathway for the disease or target condition could be improved by obtaining information in a less risky fashion or in a manner more acceptable to patients. | 65% |
Regarding the new diagnostic technology | |
8. The new technology has a clearly defined role in the diagnostic pathway, e.g. replacing an existing test, as a triage tool, or after the diagnostic pathway as an add-on test. | 58% |
9. The new technology improves the ability to rule out the disease or target condition. | 77% |
10. The safety profile of the new technology has been established. | 62% |
11. There is evidence of test accuracy in the setting in which the new diagnostic technology will be applied. | 70% |
12. The new technology improves the ability to rule in the disease or target condition. | 62% |
13. The new technology would enhance diagnostic efficiency or be more cost effective than the current diagnostic approach. | 65% |
14. It would be feasible to change current practice to incorporate this technology (e.g. additional training, infrastructure, or quality control). | 46% |
15. The new technology reduces the number of people falsely diagnosed with the disease or target condition. | 85% |
Regarding the impact of the diagnostic technology | |
16. Improved diagnostic precision using the technology would lead to improvement(s) in the delivery of treatment (e.g. shorter time to initiating treatment, reduction in morbidity or mortality). | 81% |
17. The new diagnostic technology will decrease workload in managing the disease or target condition. | 35% |
18. The cost-effectiveness of the new technology compared to existing standard practice. | 50% |